✦ LIBER ✦

Systemic Bartonella henselae infection and Crohn's disease treatment with infliximab

✍ Scribed by Alex Cañas-Ventura; Erika Esteve; Juan P. Horcajada; Montserrat Andreu; Hernando Knobel; Lucía Márquez

Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 296 KB
Volume: 18
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21858

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic amyloidosis with Crohn's diseas

Systemic amyloidosis with Crohn's disease treated with infliximab

✍ Yoon Kyung Park; Dong Soo Han; Chang Soo Eun 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

Treatment of severe esophageal Crohn's d

Treatment of severe esophageal Crohn's disease with infliximab

✍ Theo Heller; Stephen P. James; Cinthia Drachenberg; Carmen Hernandez; Dr. Peter 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 2 views

Efficacy of scheduled infliximab mainten

Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with crohn's disease

✍ Masahiro Iizuka; Shiho Sagara; Takeshi Etou 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Onset of severe perianal disease in Croh

Onset of severe perianal disease in Crohn's disease under treatment with infliximab: Successful treatment with adalimumab and setons drainage

✍ Antonio Tursi; Alfredo Papa; Michele Maiorano 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

Infliximab-induced autoimmune hepatitis

Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate

✍ K. Subramaniam; S. Chitturi; M. Brown; P. Pavli 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

Lewis and Sumner syndrome following infl

Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: A report of 2 cases

✍ Stephane Nancey; Françoise Bouhour; Gilles Boschetti; Christophe Magnier; Pierre 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

To the Editor: Neurological and demyelinating events have been reported rarely in association with the use of tumor necrosis factor a (TNF-a) antagonists, since only 29 cases were reported in patients exposed to infliximab (IFX) worldwide. These demyelinating diseases included multiple sclerosis, o